Categories
Fredun Pharmaceuticals Ltd — Board Meeting, 25-05-2026: Board Meeting
25-05-2026 · 02:57 pm
Fredun Pharma's Board has approved Q4 & FY26 audited financial results. Key approvals include a 70 paise final dividend, a 2:1 bonus share issue, and an increase in authorized capital from Rs. 10 Crores to Rs. 50 Crores.
No comments yet. Be the first to comment!